close this window
Attacking Breast Cancer in its Heel
Research suggests a possible specific target for drugs fighting the most common type of breast cancer.
Today in Mice fans already know that rodents are no stranger to cancer research. Whether it’s the discovery of the unique cancer-fighting gene of the naked mole rat or the creation of a mouse model of melanoma, we see progress as, well, progress.
A study in the Jan. 19 issue of Cancer Cell reports on researchers who believe they have identified where the most common form of breast cancer originates, which may offer a hope for better targeting drugs at the disease’s Achilles’ heel.
Specifically, researchers from Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts and the Tufts Medical Center have figured out exactly which breast cells drive the development of certain breast cancer tumors. The team, led by Charlotte Kuperwasser and Philip Hinds, also identified the protein that allows these cells to differentiate, which can ultimately lead to the runaway growth that is cancer.
Scientists have found it difficult to distinguish between the cells that make up the entire mammary tissue and those where cancer begins, and have even debated whether there was anything to distinguish. The Tufts team discovered that luminal-like breast cancers (the two most common types, and which are sensitive to hormones) originate from self-renewing cells known as lobule progenitors. When working properly, these cells create milk-producing structures in the breast tissue during pregnancy and lactation.
After identifying the cells, the researchers inhibited a protein in them, called cyclin D1, which allows them to self-renew and differentiate. Genetically altering lab mice, they made sure the gene known to cause luminal-like breast cancer was present but they also inactivated the cyclin D1. The team found that with the protein knocked out, mice didn’t develop breast tumors.
According to the researchers, the next step is to see if shutting off cyclin D1 can slow or reverse the growth of already-developing tumors. If it does, they say, breast cancer-fighting drugs might have a new target.
Sign up for our free e-newsletter.
Are you on Facebook? Become our fan.
Follow us on Twitter.
word on the street
- http://artadvice1.blogspot.com art advicer
more in this section
Neglected Tropical Diseases Neglected No More?
Something’s Fishy About That Red Snapper
Where Have All the Doctors Gone?
Do You Know Where Your Medicine Came From?
‘Fair Trade’ Chocolate Perceived as Healthier
Was Lou Gehrig’s ALS Caused by Tap Water?
Placebo Effect Stronger Than We Thought?
Feds Poke Hole in Needle Exchange Funding
FDA Cracks Whip on Lap-Band Marketing
Don’t Tax Soda, Tax Sweeteners
also by this author
Elisabeth BestFormer Miller-McCune Fellow Elisabeth Best is currently pursuing a Masters of Pacific International Affairs at the University of California, San Diego...
Lessons From China and India’s Newspaper BoomHow the print media in China and India are succeeding — and what America’s ailing journalism industry might learn from them.
Making Seed Aid BlossomThe quake in Haiti and floods in Pakistan highlight that the multimillion-dollar emergency seed aid industry is in need of a makeover.
When Migrant Workers Return HomeThousands of Latin-American migrants come to work in the United States every year, legally and illegally. But does their time in the U.S. help or hurt them when they return to their home countries?
Public Schools: An Untapped Recreational ResourceResearchers suggest limiting liability issues to make playgrounds and other recreation areas on school grounds accessible as a cost-effective way to promote public health.
Recreating the Creative Industry in New OrleansIn the wake of Hurricane Katrina, New Orleans has been rebounding slowly. Five years after the disaster, researchers suggest that the city promote its entertainment industry as a development strategy.
Receive 1 year (6 issues) of our print magazine for just $14.95. Miller-McCune features polished, in-depth reports on research and solutions across the policy spectrum — from health care, education and energy to international affairs, poverty and the global economy. It's a must read for well-informed and solutions-driven individuals.
follow us on:
join our newsletter:
from the source
The wage gap between the sexes in America has been closing much faster than anyone realized, but that’s tempered by learning it’s been much wider than measurements had shown.
An effort to identify five performing orcas as slaves failed in part, argues one scholar, because there’s no legal precedent establishing them as persons.
New research finds listeners judge symphonic music differently when they’re told the conductor is a woman.
Transportation used to be one of the few guaranteed areas of agreement when ideology trumped pragmatism in D.C. But that’s no longer the case.
New research suggests less-creative people do more innovative thinking when they are told individualism is the norm, and instructed to conform.
